🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
1.650
-0.100 (-5.71%)
At close: Nov 20, 2026, 4:00 PM EST
1.660
+0.010 (0.61%)
After-hours: Nov 20, 2026, 5:57 PM EST

Advanced Biomed Statistics

Total Valuation

Advanced Biomed has a market cap or net worth of $2.73 million. The enterprise value is $2.55 million.

Market Cap2.73M
Enterprise Value 2.55M

Important Dates

The last earnings date was Thursday, November 12, 2026, after market close.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

Advanced Biomed has 1.65 million shares outstanding. The number of shares has increased by 33.29% in one year.

Current Share Class 1.65M
Shares Outstanding 1.65M
Shares Change (YoY) +33.29%
Shares Change (QoQ) +5.57%
Owned by Insiders (%) 40.30%
Owned by Institutions (%) 6.47%
Float 986,283

Valuation Ratios

The trailing PE ratio is 0.38.

PE Ratio 0.38
Forward PE n/a
PS Ratio 21.36
Forward PS n/a
PB Ratio 0.24
P/TBV Ratio 0.24
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.42
EV / Sales 19.94
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.09, with a Debt / Equity ratio of 0.00.

Current Ratio 8.09
Quick Ratio 8.09
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -318.94

Financial Efficiency

Return on equity (ROE) is -99.40% and return on invested capital (ROIC) is -55.06%.

Return on Equity (ROE) -99.40%
Return on Assets (ROA) -46.10%
Return on Invested Capital (ROIC) -55.06%
Return on Capital Employed (ROCE) -62.42%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee $10,636
Profits Per Employee $506,244
Employee Count12
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax -1,205
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -80.04% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -80.04%
50-Day Moving Average 4.43
200-Day Moving Average 5.64
Relative Strength Index (RSI) 31.90
Average Volume (20 Days) 73,534

Short Selling Information

The latest short interest is 11,238, so 0.68% of the outstanding shares have been sold short.

Short Interest 11,238
Short Previous Month 9,747
Short % of Shares Out 0.68%
Short % of Float 1.14%
Short Ratio (days to cover) 0.31

Income Statement

In the last 12 months, Advanced Biomed had revenue of $127,637 and earned $6.07 million in profits. Earnings per share was $4.35.

Revenue127,637
Gross Profit 127,637
Operating Income -7.06M
Pretax Income -7.10M
Net Income 6.07M
EBITDA n/a
EBIT -7.06M
Earnings Per Share (EPS) $4.35
Full Income Statement

Balance Sheet

The company has $213,995 in cash and $33,477 in debt, with a net cash position of $180,518 or $0.11 per share.

Cash & Cash Equivalents 213,995
Total Debt 33,477
Net Cash 180,518
Net Cash Per Share $0.11
Equity (Book Value) 11.29M
Book Value Per Share 6.83
Working Capital 11.28M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.51M
Capital Expenditures n/a
Depreciation & Amortization n/a
Net Borrowing 917,989
Free Cash Flow -1.51M
FCF Per Share -$0.91
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -5,531.56% and 4,759.53%.

Gross Margin 100.00%
Operating Margin -5,531.56%
Pretax Margin -5,566.08%
Profit Margin 4,759.53%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Advanced Biomed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -33.29%
Shareholder Yield -33.29%
Earnings Yield 263.88%
FCF Yield -55.32%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on February 20, 2026. It was a reverse split with a ratio of 1:20.

Last Split Date Feb 20, 2026
Split Type Reverse
Split Ratio 1:20

Scores

Advanced Biomed has an Altman Z-Score of 1.2 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.2
Piotroski F-Score 2